161 related articles for article (PubMed ID: 38255847)
1. Unraveling the Role of RNA-Binding Proteins, with a Focus on RPS5, in the Malignant Progression of Hepatocellular Carcinoma.
Zhou C; Wu Q; Zhao H; Xie R; He X; Gu H
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255847
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.
Wang M; Huang S; Chen Z; Han Z; Li K; Chen C; Wu G; Zhao Y
BMC Cancer; 2020 Nov; 20(1):1136. PubMed ID: 33228611
[TBL] [Abstract][Full Text] [Related]
3. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
[TBL] [Abstract][Full Text] [Related]
4. RNA-binding protein RPS3 contributes to hepatocarcinogenesis by post-transcriptionally up-regulating SIRT1.
Zhao L; Cao J; Hu K; Wang P; Li G; He X; Tong T; Han L
Nucleic Acids Res; 2019 Feb; 47(4):2011-2028. PubMed ID: 30517713
[TBL] [Abstract][Full Text] [Related]
5. Exploration and validation of the prognostic value of RNA-binding proteins in hepatocellular carcinoma.
Wang J; Han K; Li Y; Zhang C; Cui WH; Zhu LH; Luo T; Bian CJ
Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8945-8958. PubMed ID: 36524514
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a RNA Binding Protein-Associated Prognostic Model for Hepatocellular Carcinoma.
Wang M; Jiang F; Wei K; Wang J; Zhou G; Wu C; Yin G
Technol Cancer Res Treat; 2021; 20():15330338211004936. PubMed ID: 33910445
[TBL] [Abstract][Full Text] [Related]
7. Identification of Novel RNA Binding Proteins Influencing Circular RNA Expression in Hepatocellular Carcinoma.
Razpotnik R; Nassib P; Kunej T; Rozman D; Režen T
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299096
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic analyses of RNA-binding proteins reveal eIF3c promotes cell proliferation in hepatocellular carcinoma.
Li T; Li S; Chen D; Chen B; Yu T; Zhao F; Wang Q; Yao M; Huang S; Chen Z; He X
Cancer Sci; 2017 May; 108(5):877-885. PubMed ID: 28231410
[TBL] [Abstract][Full Text] [Related]
9. The RNA-binding protein SORBS2 suppresses hepatocellular carcinoma tumourigenesis and metastasis by stabilizing RORA mRNA.
Han L; Huang C; Zhang S
Liver Int; 2019 Nov; 39(11):2190-2203. PubMed ID: 31365778
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of the tumor-promoting effect and immune infiltration correlation MAZ from pan-cancer to hepatocellular carcinoma.
Wang M; Yang X; Meng Y; Jin Z; Cao J; Xiong L; Xiong Z
Int Immunopharmacol; 2023 Feb; 115():109660. PubMed ID: 36623412
[TBL] [Abstract][Full Text] [Related]
12. Integrated bioinformatic analysis of RNA binding proteins in hepatocellular carcinoma.
Wang L; Zhang Z; Li Y; Wan Y; Xing B
Aging (Albany NY); 2020 Dec; 13(2):2480-2505. PubMed ID: 33411682
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
[TBL] [Abstract][Full Text] [Related]
14. Identification of RNA binding protein interacting with circular RNA and hub candidate network for hepatocellular carcinoma.
Cheng B; Tian J; Chen Y
Aging (Albany NY); 2021 Jun; 13(12):16124-16143. PubMed ID: 34133325
[TBL] [Abstract][Full Text] [Related]
15. LncRNA
Jiang J; Dong W; Zhang W; Wang Q; Wang R; Wang J; Wu H; Dong H; Zhao RC; Wang J; Li Z
Discov Med; 2023 Dec; 35(179):995-1014. PubMed ID: 38058065
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084
[TBL] [Abstract][Full Text] [Related]
17. RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA.
Wang Q; Guo Y; Wang W; Liu B; Yang G; Xu Z; Li J; Liu Z
Exp Cell Res; 2021 Feb; 399(1):112453. PubMed ID: 33358859
[TBL] [Abstract][Full Text] [Related]
18. MERIT: Systematic Analysis and Characterization of Mutational Effect on RNA Interactome Topology.
Li Y; McGrail DJ; Xu J; Li J; Liu NN; Sun M; Lin R; Pancsa R; Zhang J; Lee JS; Wang H; Mills GB; Li X; Yi S; Sahni N
Hepatology; 2019 Aug; 70(2):532-546. PubMed ID: 30153342
[TBL] [Abstract][Full Text] [Related]
19. RPS24 Is Associated with a Poor Prognosis and Immune Infiltration in Hepatocellular Carcinoma.
Li H; Gao L; Kang X; Wang X; Yu Y; Zhang Y; Chen H
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614249
[TBL] [Abstract][Full Text] [Related]
20. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
